Palmitate and group B


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 29 03 2024
accepted: 10 05 2024
medline: 10 6 2024
pubmed: 10 6 2024
entrez: 10 6 2024
Statut: epublish

Résumé

Rupture of the gestational membranes often precedes major pregnancy complications, including preterm labor and preterm birth. One major cause of inflammation in the gestational membranes, chorioamnionitis (CAM) is often a result of bacterial infection. The commensal bacterium Palmitate itself slightly but significantly augments GBS proliferation. Palmitate and GBS co-stimulation synergized to induce many inflammatory proteins and cytokines, particularly IL-1β and matrix metalloproteinase 9 from DSCs, CTBs, and macrophages, but not from AECs. Many of these findings are recapitulated when treating cells with palmitate and a TLR2 or TLR4 agonist, suggesting broad applicability of palmitate-pathogen synergy. Co-culture of macrophages with DSCs or CTBs, upon co-stimulation with GBS and palmitate, resulted in increased inflammatory responses, contrary to previous work in the absence of palmitate. In whole gestational membrane biopsies, the amnion layer appeared to dampen immune responses from the DSC and CTB layers (the choriodecidua) to GBS and palmitate co-stimulation. Addition of the monounsaturated fatty acid oleate, the most abundant monounsaturated fatty acid in circulation, dampened the proinflammatory effect of palmitate. These studies reveal a complex interplay between the immunological response of the distinct layers of the gestational membrane to GBS infection and that such responses can be altered by exposure to long-chain saturated fatty acids. These data provide insight into how metabolic syndromes such as obesity might contribute to an increased risk for GBS disease during pregnancy.

Identifiants

pubmed: 38855112
doi: 10.3389/fimmu.2024.1409378
pmc: PMC11158625
doi:

Substances chimiques

Interleukin-1beta 0
Palmitates 0
IL1B protein, human 0
Toll-Like Receptor 2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1409378

Informations de copyright

Copyright © 2024 Gaddy, Moore, Lochner, Rogers, Noble, Giri, Aronoff, Cliffel and Eastman.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Jennifer A Gaddy (JA)

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Tennessee Valley Healthcare Systems, Department of Veterans Affairs, Nashville, TN, United States.

Rebecca E Moore (RE)

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Publications Division, American Chemical Society, Washington, DC, United States.

Jonathan S Lochner (JS)

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, United States.
Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, United States.

Lisa M Rogers (LM)

Department Internal Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.

Kristen N Noble (KN)

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, United States.

Ayush Giri (A)

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, United States.

David M Aronoff (DM)

Department Internal Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.

David Cliffel (D)

Department of Chemistry, Vanderbilt University, Nashville, TN, United States.

Alison J Eastman (AJ)

Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH